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Abstract
Study Objectives: Insomnia has been on the rise during the 2019 coronavirus disease (COVID-19) pandemic, which may disproportionately
affect racial minorities. This study characterized racial disparities in insomnia during the pandemic and evaluated mechanisms for such
disparities.
Methods: Participants included 196 adults (48 Black) from a 2016–2017 clinical trial of insomnia treatment who were reevaluated in April
2020. Race was evaluated as a predictor of change in insomnia, impact of COVID-19, and COVID-19 stress. Mediation models using the
PRODCLIN method evaluated the extent to which: (1) COVID-19 impact accounted for Black-White disparities in change in insomnia, and (2)
COVID-19 stress accounted for associations between discrimination and change in insomnia.
Results: Increases in insomnia symptoms during COVID-19 were greater in Black compared to White participants, with 4.3 times the odds of
severe insomnia (Insomnia Severity Index ≥ 22). Symptom severity was associated with pre-pandemic experiences of discrimination. Black
participants were also disproportionately impacted by COVID-19, with twice the odds of irreparable loss of income/employment and four
times the rate of COVID-19 diagnoses in their sociofamilial network compared to White participants. The disproportionate impact of COVID19 accounted for 69.2% of the relationship between race and change in insomnia severity, and COVID-19 related stress accounted for 66.5% of
the relationship between prior history of racial discrimination and change in insomnia severity.
Conclusions: Black-White disparities in insomnia severity during COVID-19 may be driven by structural inequities resulting in the
disproportionate impact of COVID-19 on Black Americans. Results lend support for the minority stress model in the context of sleep health.
Clinical Trial Registration: Sleep to Prevent Evolving Affecting Disorders (SPREAD). NCT number: NCT02988375. https://clinicaltrials.gov/ct2/
show/NCT02988375.

Statement of Significance
This study examined the racial disparities in insomnia during the 2019 coronavirus disease (COVID-19) pandemic and tested mechanisms
driving such disparities. Results document Black-White disparity in insomnia severity, impact on daily life from the COVID-19 pandemic,
and COVID-19 related stress, which likely stem from long-standing structural racism. Results also demonstrate that this Black-White disparity is driven by the disproportionate impact of the COVID-19 pandemic on Black relative to White Americans due to structural racism.
Finally, results also lend support for the role of minority stress in racial disparities in sleep health, with results indicating that experiences
of racial discrimination before the pandemic potentiated the impact of the pandemic on stress and insomnia.
Key words: COVID-19; insomnia; health disparities; discrimination; minority stress
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Introduction

Downloaded from https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsab242/6425588 by Henry Ford Hospital user on 29 December 2021

Among the long-standing challenges made even more salient by
the 2019 Coronavirus Disease (COVID-19) pandemic is the pervasiveness and severity of racial health disparities in the United
States. In fact, amidst the pandemic, the Centers for Disease
Control and Prevention declared racism a serious public health
threat, exemplified by the significantly higher rates of COVID-19
infection and mortality among Black relative to White Americans
[1–3], and by the rise in violence against Asian-Americans and
Pacific Islanders due to the national scapegoating of Chinese
people for the coronavirus [4]. Many more occurrences during
the COVID-19 pandemic have highlighted the multifactorial
complexities that cause and maintain racial disparities.
Apart from coronavirus infection, the COVID-19 pandemic
has also had health consequences extending well-beyond
symptoms of the virus. Increases in mental health problems,
including symptoms of insomnia, posttraumatic stress, anxiety,
and depression have already been observed in the context of
COVID-19 [5–9]. As a consequence, COVID-related disability and
mortality will include impairment from mental illness, which
is already a leading contributor to global disease burden [10].
Insomnia has been among the most prevalent problems during
the pandemic, with the prevalence of clinically significant insomnia increasing between 47% and 189% [11, 12] compared
to before the pandemic [13]. Importantly, insomnia is a robust
risk factor for a cascade of medical and psychiatric morbidities,
making it an important variable in health trajectories. Sleep disturbances and insomnia have been described as fundamental
contributors to health disparities in cardiovascular disease [14].
Emerging research also indicates that early intervention for insomnia may significantly improve stress and resilience [15], and
reduce concurrent depression and prevent incident depression
by 50% [16–18].
Despite being a significant problem during the COVID-19
pandemic, the racial disparity in insomnia symptoms during
the pandemic has not been well-characterized. Though the
landscape of racial disparities research in insomnia prior to
the COVID-19 pandemic has been mixed, there is growing evidence that Black Americans and people from other minoritized
races experience more severe insomnia than White Americans.
For example, relative to White Americans, Black Americans
have a 67% increased risk of insomnia disorder with short sleep
[19], which is among the most severe phenotypes of insomnia
[20]. Furthermore, a large prospective study found that Black
Americans were two times more likely to exhibit chronic insomnia (>1 year) than White Americans [21]. Research using objective measures of sleep also found that racially minoritized
individuals exhibit longer sleep latencies and wake after sleep
onset [22]. Given that Black Americans have been disproportionately impacted by COVID-19, it is likely that the disparity in insomnia would widen during the pandemic.
In addition to characterizing the racial disparities in insomnia, it is equally important to identify mechanisms driving
such disparities to avoid the conflation of race as a risk factor
as opposed to a social construct that functions as a proxy for
racism. Specifically, the mechanisms driving adverse health outcomes in racial minorities are not caused by an individual’s race
but instead by the various social and structural barriers to health
that disproportionately impact minoritized individuals. For example, prior studies have identified perceived discrimination
as a critical mechanism driving more severe sleep disturbances

and insomnia in communities of Black, Indigenous, and people
of color [23–29]. Indeed, those who report higher levels of discrimination have increased odds of moderate to severe insomnia (54% and 84% increase, respectively), and also generally
show less sleep that is of worse quality [23, 29]. Furthermore,
these effects are likely exacerbated by the additional stress of a
global pandemic [30].
Beyond interpersonal discrimination, there are systemic
social and structural inequities that may further account for
racial/ethnic disparities in sleep health and insomnia. For example, acculturation stress and chronic stress are associated
with greater insomnia symptom severity in Latinx/Hispanic
adults [27, 28]. Furthermore, associations between insomnia and
race/ethnicity are often attenuated or eclipsed by associations
between insomnia symptoms and socioeconomic factors downstream from structural discrimination (e.g. employment status,
education, food security, night work, noisy neighborhood) or
health indicators (e.g. body mass index, physical activity, health
problems) [27, 31–36]. Disparities in stress exposure, economic
prosperity, and access to health care are also probable explanatory factors for racial disparities that would be exacerbated due
to the COVID-19 pandemic, which together can then potentiate
worse insomnia symptoms.
In examining racial disparities during the COVID-19 pandemic, it would be remiss to ignore the long history of racial discrimination that predates and potentiates the disproportionate
burden of the pandemic on marginalized individuals. For these
individuals, the COVID-19 pandemic compounded pre-existing
social and structural racism. For example, the disproportionate
COVID-19 infection and mortality rates in Black Americans stem
from long-standing structural racism that have led to increased
exposure to the virus (e.g. due to occupational and/or living circumstances that limit the ability for social distancing and selfisolation), limited and differential access to healthcare services
(e.g. COVID-19 testing and care), and limited access to accurate
and updated COVID-19 risks and recommendations. These are
additive to the racism predating the pandemic; for example, in
addition to George Floyd’s fatality driven by racial discrimination and institutional racism, a postmortem positive antigen
test indicated that he also exhibited persistent viral activity
from a prior COVID-19 infection [37]. Similarly, violence during
the pandemic is reminiscent of both on-going and past racial
traumas [38–40], which is additive to the generalized stress of a
pandemic. Even indirect exposure to discrimination (e.g. media
documentation of the murder of George Floyd) can trigger vicarious experiences of discrimination in marginalized individuals [41–43], which would only compound pandemic stress and
exacerbate insomnia.
The potentiation of worse insomnia in marginalized individuals during the pandemic due to prior stress is consistent with
the minority stress model, which has been used as a critical
framework for understanding health disparities [44–46]. This
model posits that minorities experience stress that is unique
and chronic, arising from social and structural inequities that
are additive to general stressors experienced by all people. The
accumulation of minority stress, in turn, drives adverse health
outcomes in marginalized individuals. Indeed, research has already implicated long-standing and pre-existing disparities in
metabolic burden in Black Americans (e.g. obesity, hypertension, and diabetes) as key drivers of the greater susceptibility
to COVID-19 infection and mortality along with other negative
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Methods
Participants for this study were recruited from a previous randomized controlled trial (Sleep to Prevent Evolving Affecting
Disorders [SPREAD] trial: NCT02988375) that tested the efficacy of insomnia treatment in preventing incident depression
[16, 17]. Participants received either digital Cognitive Behavioral
Therapy for insomnia (dCBT-I) or a treatment-as-usual (TAU)
condition that comprised sleep education. Participants in the
SPREAD trial were enrolled between 2016 and 2017, with a final
sample of 358 in the dCBT-I condition and 300 in the control
condition. Those in the dCBT-I condition completed six sessions
of dCBT-I, and those in the TAU sleep education condition received six weekly e-mails based on the National Institutes
of Health (NIH) guide to healthy sleep [50]. All treatment and
study materials were provided in English. Eligible participants
met criteria for insomnia disorder based on the Diagnostic and
Statistical Manual of Mental Disorders (5th ed.; DSM-5), and
participants were excluded if they reported a diagnosis of any
untreated sleep disorders other than insomnia (e.g. obstructive
sleep apnea, restless legs, narcolepsy, etc.), or bipolar or seizure
disorders. Because the SPREAD trial included a depression prevention aim, individuals with high depression chronicity (selfreported daily or near-daily depressed mood and anhedonia)
were excluded (see Cheng et al. [17] for additional details).
All 658 participants in the SPREAD trial were eligible for
this follow-up study. The recruitment plan targeted enrollment at 200 participants to achieve sufficient statistical power
to evaluate the primary study aims. Email invitations were sent
during the last week of April 2020, 5 weeks into the Michigan
state-wide stay-at-home order, with approximately 40 000 cases
and 3800 deaths across the state. Enrollment was closed in the
first week of May when the targeted sample size was achieved.
The sample included 208 participants; of these individuals, only
one identified as Asian, eight reported race unknown (or did not
wish to report), and three identified with more than one race.

Only two White participants endorsed an ethnicity of Hispanic
or Latino. Both race and ethnicity data were self-reported. Given
the small size of the subgroups, the final analyses included 196
individuals who reported their race as either Black (n = 48) or
White (n = 148).

Measures of interest
Insomnia. Symptoms of insomnia were assessed using the
7-item Insomnia Severity Index (ISI) [51], with higher scores
indicating increased insomnia severity (range 0–28). To establish
precedence in the mediation analysis to support causal inferences, posttreatment ISI scores from before the COVID-19 pandemic was subtracted from ISI measured during the pandemic
to produce a measure of resurgence of insomnia symptoms.
Additionally, because the ISI is not designed to assess insomnia in response to a specific event, a prompt was included
to assess the impact of the COVID-19 pandemic on sleep using
a four-point Likert scale. The prompt was, “How much impact did
the COVID-19 pandemic have on your sleep?”, and responses ranged
from Not at all (0) to Very much (4). Results from this item were
examined independently and were not incorporated into the ISI.
Coronavirus Impact Scale. Degree of impact on daily life from
the COVID-19 pandemic was measured using the Coronavirus
Impact Scale (CIS). The CIS was made available through a collection of COVID-19 Research Tools assembled by the Office of
Behavioral and Social Sciences Research at the NIH [50]. The CIS
rates the degree of change across 11 domains of daily life on a
four-point Likert scale (0 = no change, 1 = mild, 2 = moderate,
3 = severe). Domains assessed included routines; income/employment; access to food, medical care, and mental treatment;
access to social support; pandemic related stress; familial stress
and discord; and diagnoses and severity of COVID-19 in immediate as well as extended family and/or close friends. The scale
has adequate internal consistency (α = 0.64–0.75) and validity,
with mean scores ranging from 9.2 to 12.0 across five validation
samples that consisted of primary caregivers (https://psyarxiv.
com/kz4pg/).
COVID-19 related stress. Stress and trauma specific to the COVID19 pandemic were assessed using the 22-item Impact of Events
Scale [52] (IESCOVID-19). The IES measures the amount of distress
associated with a specific event. Although the IES allows individuals to specify the event in question, we predetermined “the
COVID-19 pandemic” in the instructions as we were interested
in measuring stress specifically associated with the COVID-19
pandemic. The total score on the IES ranges from 0 to 88. The
IES score comprises three component scores: cognitive intrusion, avoidance, and hyperarousal. Both cognitive intrusion and
avoidance describe psychological experiences of stress prior to
the assimilation of the trauma, the cognitive intrusion reflecting
repeated thoughts about the trauma, and avoidance reflecting
effortful avoidance of reminders of the trauma. The third component describes physiological hyperarousal as a cluster of
post-traumatic stress disorder symptoms.
Racial discrimination. Racial discrimination was assessed during
the 2016–2017 SPREAD trial via a single-item measure from
the Commonwealth Fund 2001 Health Care Quality Survey [53]
and the 2003 California Health Interview Survey [54]. These are
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health outcomes [30, 47]. Additionally, COVID-19 related psychosocial stress (e.g. social isolation from quarantine) may further
exacerbate pre-existing disparities (e.g. reduced sense of belonging due to racial discrimination) that then widen the racial
disparity in insomnia severity during the pandemic [23, 24, 30].
The overarching aim of this study was to characterize racial disparities in insomnia during the COVID-19 pandemic
and evaluate mechanisms driving such disparities. These aims
were part of a larger study that examined resilience in the sleep
and stress systems during the COVID-19 pandemic in a sample
of adults who completed treatment for insomnia prior to the
pandemic [48]. Participants in this trial predominantly resided
in the Detroit metropolitan area, which was disproportionately
impacted by the COVID-19 pandemic [49]. We hypothesized that
Black participants would experience more insomnia, COVIDrelated disruptions to daily life, and COVID-related stress compared to White participants. We also hypothesized that the
disproportionate impact of the COVID-19 pandemic would partially mediate racial disparities in increased insomnia during
the pandemic. In addition, based on a minority stress model
in which prior discrimination compounds the impact of future
stressors, we tested the hypothesis that discrimination (prepandemic) would potentiate increased insomnia during the
pandemic through increases in COVID-19 specific stress.
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Analytic approach
All models in this manuscript (except those testing demographic
differences) included treatment condition, sex, and household
income (coded as an ordinal variable, see Table 1) as covariates.
Age was included as a covariate during model building but
was removed from the final models due to non-significance.
Sensitivity analyses were also conducted in a subsample of females to examine potential effects of intersectionality [59, 60];
however, analyses were precluded from the final analyses due to
redundancy with the full sample.
Racial disparities in the impact of the COVID-19 pandemic on
insomnia (ISI) were tested using linear regressions. Racial disparities in daily life during the pandemic (CIS) and COVID-19 specific stress (IESCOVID-19) were tested using multivariate regression
models accounting for all variables within the same models (i.e.
the domains of functioning on the CIS, and the three subscales
on the IESCOVID-19) to reduce the risk of family-wise error. Racial
disparities were tested using the omnibus effect of race across
all dependent variables in the multivariate model, and beta coefficients of race as the predictor (adjusted and standardized)
were used to explore the magnitude of potential differences in
subcomponents. Because two items on the CIS were count variables (i.e. count of family members diagnosed with COVID-19),
negative binomial models were used to generate an incident
rate ratio as the parameter estimate.
To examine disparities in the impact of the pandemic as a
mechanism contributing to Black-White disparities in increased
insomnia severity during the pandemic, a mediation analysis
was conducted in accordance with procedures outlined by
Fairchild and MacKinnon [61], with significance testing of the
indirect effect using the distribution of the product approach
(i.e. the PRODCLIN method) implemented in R [62]. This method
Table 1. Baseline sample characteristics by group

Age (M ± SD)
Sex (female)
2019 household income
Very low (<15k)
Low (<35k)
Middle (<75k)
High (≥75k)
Pre-COVID ISI (M ± SD)
Received dCBT-I
Perceived discrimination

White (n = 148)

Black (n = 48)

45.7 ± 14.2
73.6%

43.0 ± 12.9
93.8%

6.8%
24.3%
33.8%
35.1%
9.2 ± 6.2
51.0%
0.39 ± 0.67

10.4 %
16.7%
52.1%
20.8%
10.8 ± 5.6
40.0%
1.50 ± 1.01

No group differences were detected except for sex and perceived
discrimination.
dCBT-I, digital Cognitive Behavioral Therapy for Insomnia.

is less vulnerable to Type I errors compared to traditional significance tests [63], and does not assume a normal distribution,
which allows for asymmetric confidence intervals (CIs) [64, 65].
Statistical significance was determined if the 95% CI for the indirect effect did not include zero. The parameters required for
the PRODCLIN approach (pathways α, β, c, and c′) were determined via three ordinary least squares regression models with
covariates. Specifically, three regression models were conducted
for the mediation analysis (see Figure 1): (1) the direct effect of
the predictor (race) on the outcome variable (change in insomnia
severity, i.e. ISI during the pandemic − ISI pre-pandemic), (2) the
effect of the predictor (race) on the proposed mediator (impact
of the COVID-19 pandemic), and finally (3) the effect of the mediator on the outcome variable. The indirect (i.e. mediated) effect
of the predictor on the outcome variable was tested using the
product of the α and β parameter estimates.
We also examined perceived discrimination pre-pandemic
as a predictor of pandemic-related stress (IESCOVID-19) and change
in insomnia severity (i.e. ISI during the pandemic − ISI prepandemic), controlling for treatment condition, sex, household
income, and race as covariates. Finally, we tested COVID-19 specific stress (IESCOVID-19) as a mediator in the relationship between
prior perceived discrimination and change in insomnia severity
during the pandemic (see Figure 1). In contrast with the first mediation model that tested CIS as a mediator, COVID-19 specific
stress (IESCOVID-19) was selected a priori as the mediator for this
analysis because it is better aligned with the minority stress hypothesis that specifically posits the accumulation of stress as a
driving mechanism of health outcomes.1
Given that research conducted during a global pandemic
may be vulnerable to selection bias [66, 67], we utilized sampling
weights for all analyses to mitigate differences in the probability
of selection into the study relative to the original population of
SPREAD trial participants. Sampling weights equal to the reciprocal of the selection probability in each condition were used to
balance the probability of selection based on insomnia severity
following treatment in the SPREAD trial. Insomnia severity was
categorized as non-clinically significant (ISI ≤ 7), subthreshold
(ISI > 7 and ≤ 14), or clinically significant (ISI ≥ 15). The final
weighted mean (9.8 ± 5.7 SD) did not differ significantly from the
population mean (10.4 ± 5.8 SD). Additionally, comparison of the
final sample in this study to those in the SPREAD trial revealed
no differences in treatment compliance [t(840) = 1.104, ns],
moderate-to-severe insomnia at post-treatment [χ2(1) = 0.581,
ns], insomnia remission at post-treatment [χ 2(1) = 2.27, ns], nor
by demographic variables (race: χ 2(1) = 0.120, ns; age: t(864) = 0.25,
ns; sex: χ 2(1) = 0.017, ns; and income: χ 2(3) = 2.5, ns). Together,
these data suggest that selection bias was likely minimal.

Results
Demographics
The final sample comprised 196 participants (see Table 1 for a summary of sample characteristics by group). On average, the sample
age was 44.7 ± 14.1 SD, 78.4% female, and reported mild ISI scores
(12.2 ± 6.9 SD). Black participants in this COVID follow-up study
were more likely to be female (χ2[1] = 7.55, p < .01) and reported
more discrimination (F[1,194] = 77.31, p < .001) compared to White
Analyses using CIS as a mediator yielded similar results.

1
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validated and population-based surveys that are widely cited in
academic research [55–57], and used in briefings for Congress
and other governmental agencies to increase equity in health
care policies. The prompt was “Thinking about your race or ethnicity, how often have you felt treated badly or unfairly because of your
race or ethnicity.” with responses ranging from 0 to 4 (“Never” to
“All the time”) and treated as a continuous variable in analyses.
The construct validity of this measure has been demonstrated
using health outcomes known to be associated with other measures of racism [55, 57, 58].
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participants. There were no Black-White differences in income
(b = −0.27 ± 0.30, ns), receipt of dCBT-I (b = −0.45 ± 0.34, ns), or posttreatment pre-pandemic insomnia symptoms (b = 0.36 ± 0.84, ns).

Disparities during the COVID-19 pandemic
Insomnia. While no racial differences in insomnia were detected
acutely following insomnia treatment in 2016–2017, Black participants reported more severe insomnia symptoms during the
COVID-19 pandemic compared to White individuals after controlling for pre-COVID insomnia severity, treatment condition, sex,
and household income, B = 0.37 ± 0.16 SE, p < .05 (see Table 2).
Additionally, the odds of severe insomnia (ISI ≥ 22) was 4.2 times
higher in Black compared to White participants, 95% CI = 2.4 to
7.3, p < .001. To further link sleep disturbances to COVID-19, an
additional analysis also examined the extent to which sleep disturbances were attributed to COVID-19. Results showed that black
participants attributed their sleep difficulties more to the COVID19 pandemic than White participants, B = 0.40 ± 0.17 SE, p < .05.
Coronavirus Impact Scale. After accounting for covariates, the
multivariate regression analysis indicated that Black participants were more severely impacted by the pandemic compared to White participants, F(26, 382) = 2.5, p < .001. This was
reflected in the beta coefficient (standardized and adjusted) for
the total CIS score, B = 0.61 ± 0.16 SE, p < .001, with the mean
score for Black participants falling above the range found in
primary caregivers during the pandemic (see Table 2 for summary statistics). Follow-up to the omnibus effect showed
that Black-White differences were most pronounced in the

Table 2. Racial differences in the impact of the COVID-19 pandemic
adjusted for treatment condition, sex, and household income
White (n = 148) Black (n = 48) Statistical test values
ISI
11.2 ± 6.6
CIS
11.0 ± 4.5
IESCOVID-19 24.5 ± 12.8

14.8 ± 7.6
14.2 ± 5.3
33.6 ± 17.0

t(194) = 3.2, p < .001, d = 0.51
t(202) = 4.1, p < .001, d = 0.65
t(202) = 3.3, p < .001, d = 0.60

As reference, the range of CIS scores across five samples of primary caregivers
during the pandemic was 8–12 (https://psyarxiv.com/kz4pg/).
ISI, Insomnia Severity Index; CIS, Coronavirus Impact Scale; IESCOVID-19, Impact of
Events Scale specific to the COIVD-19 pandemic; d, Cohen’s d.

domains of disturbances to family income/employment, diagnosis and symptom severity of COVID-19 in immediate family
members, and diagnosis and symptom severity of COVID-19
in extended family members and/or close friends. Specifically,
Black participants reported greater loss of family income/employment compared to White participants, B = 0.38 ± 0.17 SE,
p < .05, with twice the odds of being unable to meet essential needs or fiscal responsibilities, OR = 2.04, 95% CI = 1.1 to
3.8. Incidence rate ratios indicated that COVID-19 diagnoses
in immediate family members were 2.3 times higher in Black
versus White participants, 95% CI = 1.6 to 3.3, with symptoms
that were also more severe, B = 0.65 ± 0.16 SE, p < .001. The
Black-White disparity in COVID-19 diagnoses and severity was
even higher in extended family members and/or close friends:
the incidence rate ratio indicated that COVID-19 diagnoses
were 4.0 times higher in Black versus White participants, 95%
CI = 3.1 to 5.1, with symptoms that were also more severe,
B = 1.11 ± 0.15 SE, p < .001.
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Figure 1. Schematic of the mediation analyses. All analyses adjusted for treatment condition, sex, and household income as covariates. Pre-COVID-19 insomnia severity was subtracted from COVID-19 era insomnia severity to better approximate insomnia associated with the COVID-19 pandemic. Parameter estimates are included
for the pathways. *p < .05.
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Associations between race, COVID-19 impact, and
COVID-19 insomnia severity
Mediation analysis supported a significant direct effect in which
Black participants reported greater resurgence of insomnia
symptoms during the COVID-19 pandemic compared to White
participants (pathway c: B = 0.40 ± 0.16 SE, p < .05; difference
of 3.1 points on the ISI), after adjusting for treatment condition, sex, and 2019 annual household income. As demonstrated
above, Black participants were also disproportionately impacted by the COVID-19 pandemic (pathway α: B = 0.63 ± 0.16
SE, p < .001). Finally, CIS scores remained a significant predictor
of insomnia severity even after adjusting for race (pathway β:
B = 0.44 ± 0.06 SE, p < .001), but the Black-White disparity in insomnia severity was no longer statistically significant after
adjusting for CIS scores (pathway c′: B = 0.12 ± 0.15 SE, ns). The
95% CI of the indirect effect did not overlap with zero (α × β: 0.28,
95% CI = 0.12 to 0.47), and the indirect effect accounted for 69.2%
of the greater increases in insomnia severity in Black compared
to White participants.

Associations between prior racial discrimination,
disparities in COVID-related stress, and COVID-19
insomnia severity
Mediation analysis demonstrated that more frequent encounters of racial discrimination prior to the pandemic predicted
greater resurgence of insomnia symptoms during the pandemic
(pathway c: B = 0.20 ± 0.08 SE, p < .01; b = 1.7 points on the ISI).
Racial discrimination also potentiated COVID-19 related stress
(pathway α: B = 0.23 ± 0.08 SE, p < .01). Finally, COVID-related
stress remained a significant predictor of greater increases in
insomnia severity even after adjusting for history of racial discrimination (B = 0.56 ± 0.06 SE, p < .001); however, discrimination was no longer a significant predictor of insomnia severity
(pathway c′: B = 0.07 ± 0.07 SE, ns). The 95% CI of the indirect
effect did not overlap with zero (α × β: 0.13, 95% CI = 0.04 to
0.24), and the indirect effect accounted for 66.5% of the relationship between racial discrimination and increases in insomnia
severity during the COVID-19 pandemic.

Discussion
The aims of this study were to characterize racial disparities of
insomnia during the COVID-19 pandemic and evaluate mechanisms driving such disparities. This was conducted in a sample
of individuals who received behavioral treatment for insomnia
prior to the pandemic. As expected, we found that Black participants were disproportionately impacted by the pandemic,
particularly in the domains of family income and employment
as well as higher rates of COVID-19 diagnosis and severity in

social and familial networks. We also found that Black participants exhibited more severe insomnia during the pandemic
after adjusting for covariates including household income,
which suggests that this racial disparity cannot be solely explained by socioeconomic differences. This finding is especially
notable as no significant racial differences in insomnia severity were found in the same sample prior to the pandemic
after receiving insomnia treatment in 2016/2017. Furthermore,
the Black-White disparity in insomnia severity during the pandemic in this sample was approximately threefold the magnitude of disparities found pre-pandemic [17, 68], suggesting that
the racial disparities in insomnia grew in conjunction with the
disproportionate social stressors during the pandemic. Results
also indicated that Black participants reported higher levels of
COVID-related stress compared to White participants, and that
this stress was associated with a history of perceived racial discrimination prior to the pandemic.
This study also provided evidence that the disproportionate
impact of the pandemic on Black Americans may be a key mechanism driving Black-White disparities in insomnia symptoms.
This lends further support that racial disparities in insomnia
likely result from structural inequities that impact health outcomes. For example, historical barriers to property ownership
and social mobility (e.g. mortgage redlining [69], high-density
housing [70], discriminatory hiring practices [71, 72], income inequality [73]) likely rendered protective measures out-of-reach,
such as social distancing and self-isolation. Additionally, the
existing wealth gap between Black and White Americans [74]
likely resulted in the more Black Americans needing to continue
work through the pandemic. Combined with the fact that Black
Americans are overrepresented in industries with front-line
workers and without worker protections (e.g. paid sick leave)
[75], these disparities exacerbate the risk for and consequences
of coronavirus exposure. Together, these long-standing structural inequities likely lead to disproportionate social stressors
that precipitated a resurgence or exacerbation of insomnia
symptoms, especially in a vulnerable sample with a history of
insomnia disorder. Indeed, the mediation model indicated that
a significant majority (approximately 70%) of the racial disparity
in insomnia severity was explained by the disproportionate impact of the pandemic on Black Americans.
Our results provide further support for the role of minority
stress in disparities in sleep health. Specifically, we found that
those who reported more frequent experiences of racial discrimination prior to the pandemic also reported more severe
COVID-19 specific stress and exhibited more severe insomnia.
This aligns with the minority stress model in which minoritized
people experience the compounding accrual of unique and
chronic social stressors that result in worse long-term health
deficits than non-marginalized individuals [44]. Indeed, our
results support the hypothesis that higher COVID-19 specific
stress mediates the relationship between discrimination and
increased insomnia symptoms during the pandemic, suggesting
that COVID-19 specific stress may be tapping into a similar or
related latent construct as racial discrimination despite a relatively weak correlation (r = .22). In this context (and in alignment with components of the minority stress model), it may
be that experiences of discrimination potentiates increased
vigilance [76] (e.g. hyperarousal) and expectancies of adverse
outcomes due to the COVID-19 pandemic (and thus worry and
rumination), which then exacerbate insomnia symptoms and/
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COVID-19 related stress. The multivariate regression analysis
indicated that Black participants also reported greater COVID19 related stress compared to White participants, F(6,402) = 2.5,
p < .05 (see Table 2 for summary statistics). The adjusted coefficients indicated that Black participants scored higher than
White participants on all three subscales of the IESCOVID-19: intrusion, B = 0.41 ± 0.14 SE, p < .01; avoidance, B = 0.53 ± 0.17 SE, p <
.01; and hyperarousal, B = 0.40 ± 0.17 SE, p < .05.
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the differences found in this sample were not due to the effect
of prior treatment type.
Additional research is also needed to examine the impact of
the COVID-19 pandemic on other high-risk populations. For example, there is a need for additional work to examine the impact of the COVID-19 pandemic on Asian American and Pacific
Islanders (AAPI) given the rise in anti-Asian racism [39]. The
physical and economic assault against AAPI (e.g. xenophobic
attacks against Asian restaurants and businesses) are reminiscent of past racial traumas and exclusionary measures such
as the Chinese Exclusion Act (federal law prohibiting immigration of Chinese people, including laborers who were critical to building the US infrastructure, e.g. the transcontinental
railroad), the Japanese Internment (incarceration of JapaneseAmerican citizens in concentration camps during World War
II), and People v. Hall (law barring any individuals of Chinese
descent to testify against White people). Similarly, more work
is needed to examine the impact of the COVID-19 pandemic on
Hispanic/Latinx populations, which represent the largest ethnic
minority group in the United States, and Native American and
Indigenous peoples. These communities that have been disproportionately impacted by the COVID-19 pandemic and may be
especially likely to experience potentiation of COVID-related
stress due to historical trauma resulting from colonially-based
disease, restriction of geographic and social mobility, and medical abuse and neglect. In addition, this study is underpowered to examine the compounding and interactive effects of
sociodemographic characteristics other than race (e.g. gender).
Intersectionality between minoritized social statuses likely contribute to sleep health disparities, but they are inadequately
understood and rarely evaluated [82].

Conclusion
This study found that Black Americans were disproportionately
impacted by the COVID-19 pandemic, and COVID-19 impact partially mediated racial disparities in insomnia symptoms during
the pandemic. Indeed, the Black-White disparity in insomnia
severity was almost threefold more severe than pre-pandemic
levels, even though this sample received treatment for insomnia
prior to the pandemic. This study also demonstrated that racial
discrimination was associated with an exacerbated impact of
the COVID-19 pandemic. These results suggest that prevention and intervention for COVID-related increases in insomnia
symptoms may depend upon relief from structural inequities
in employment, income, and healthcare among other forms
of discrimination experienced by Black Americans. Future research should examine the impact of the COVID-19 pandemic
and sleep in other marginalized and intersectional groups (e.g.
the AAPI community, minoritized women versus men), and how
disparities in sleep health may be improved with more structural equity in the United States.
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or depletes cognitive and emotional resources that would otherwise be deployed for coping and emotional regulation. However,
it should be noted that this sample was not adequately powered
to parse this indirect effect by race (i.e. COVID-19 stress as a
mediator between discrimination and insomnia), which would
speak more directly to a racial disparity. As such, interpretation
of these results should be tempered before this comparison is
made in future research.
The strengths of this study include the use of a longitudinal
sample that enabled comparison of insomnia severity prior to
the onset of the pandemic. Furthermore, individuals in this
sample had received behavioral treatment for insomnia that attenuated prior racial disparities in insomnia severity [77], which
mitigates pre-COVID disparities as a confounding variable. This
research also provides an important contribution to our understanding of the highlighted and exacerbated sleep health disparities seen in Black Americans during the global COVID-19
pandemic.
There are some limitations to consider regarding the generalizability of these results. First, this sample only included those
who previously had exposure to a sleep intervention (including
CBT-I) which likely bolstered health and functioning during the
pandemic [48]. As such, true magnitude of disparities in the
greater population is likely larger than that represented in this
sample. Second, our results were limited to Black-White disparities because there was inadequate representation of other races
in the sample, resulting in insufficient power to parse analyses
by other races/ethnicities. Furthermore, the sample was not
balanced by Black and White participants, with fewer number
of Black participants which limited more complex analyses that
parse effects by race.
Additional considerations regarding the generalizability
of these results include that the data were collected in April
2020, and thus may not represent the effects of race or discrimination on insomnia and COVID-related life impact and
stress later in the course of the pandemic. Participants were
also sampled from communities in the Detroit metropolitan
area and may not generalize to other geographic regions, although findings have been consistent with national reports
of racial disparities during the COVID-19 pandemic. A few
studies examining insomnia symptoms during the COVID-19
pandemic found that urban citizens scored higher in overall
insomnia symptoms than rural residents [12, 78]. These results suggest that individuals living in bigger cities may be at
a greater risk for insomnia. Rural residence may act as a buffer
providing more opportunities for outside physical activity,
exposure to natural environments, and less restriction as exposure risk is lower. There are also methodological considerations when interpreting the study results. First, insomnia
symptoms were assessed concurrently with COVID-19 impact
and stress, and insomnia can contribute to mental health and
immune function [79]. Causal inferences about the effects of
COVID-19 impact and stress on insomnia symptoms should be
tempered by the bidirectional associations between insomnia
symptoms, perceived stress, and health outcomes. Another
important consideration is that individuals received two different treatments (i.e. dCBT-I and sleep education). Although
prior reports indicate that insomnia improved in both treatment conditions [16, 17], CBT-I is the recommended first-line
treatment for insomnia [80, 81]. However, all models controlled for treatment condition as a covariate, suggesting that
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